Kinetics Flashcards
what are the main causes of the main alterations in ADME
- age
- genetic factors
- end organ damage
- drug interactions
what are the types of variability in ADME
- pharmacokinetics
- pharmacodynamic
- idiosyncratic
describe idiosyncratic variability
- occur in a small minority of patients
- sometimes with low or normal doses
- poorly understood
what is a pharmacodynamic interaction
interaction between 2 or more drugs that leads to:
-accentuation/synergism
- attenuation/antagonisn
what is an example of accentuation/synergism
calcium channel blocker and a beta blocker
what is an example of attenuation/antagonism
narcan and opiods
do pharmacodynamic interactions have to do with ADME
no
do pharmacokinetic interactions have anything to do with ADME
yes
what drugs do we need to check for interactions with/what drugs have many other drug interactions
- warfarin
- digoxin
- TCAs
- phenytoin
- carbamazepine
- lithium
- methotrexate/cyclosporine/tacrolimus
- HIV medications - protease inhibitors
- rifampin
- paxlovid
what is the result of the interaction of tetracycline and antacids
antacid impairs absorption of ABX resulting in decrease ABX efficacyw
what is the result of the interaction between erythromycin/clarithromycin/ metronidazole/ciprofloxacin/trimethaprim- sulfamethoxazole and warfarin
ABX inhibits the metabolism of warfarin resulting in increased serum concentration of warfarin and increasing the risk of bleeding
what is the result of the interaction between NSAID and warfarin
additive effect on decreased platelet aggregation resulting in additive risk for bleeding, especially GI bleeding
what is the result of the interaction between ASA and warfarin
additive effect on decreased platelet aggregation ->additive risk for bleeding, especially GI bleeding
what is the result of the interaction between tramadol and antidepressants
increased risk of serotonin syndrome
what is the result of the interaction between protease inhibitors and BZD
protease inhibitors are CYP 450 3A4 inhibitors -> decreased metabolism of benzodiazepine -> increased benzodiazepine concentrations -> increased risk of benzodiazepine side effects which are increased sedation depth and duration
what are the things to consider with pregnant patients
- increased cardiac output increases distribution of drugs
- increased renal blood flow increases elimination of drugs and decreases the duration and effects of drugs
- decreased albumin which decreases binding of drugs -> more free drug to act -> drugs have more pronounced effects
what are the considerations for patients with uncontrolled DM
- gastric stasis -> decreases rate of absorption of drugs
- nephrotic syndrome -> glomerulus gets damaged -> protein gets in kidneys -> proteinuria -> damages kidneys and generalized edema in body -> decreases rate of absorption of drugs -> decreased albumin -> more pronounced drug effect
what medications will worsen myasthenia gravis
- aminoglycosides
- fluoroquinolones
- tetracyclines
- macrolides
- magnesium
- beta blockers
- procainamide
- neuromuscular blockers
what is a side effect and give example
unrelated to clinical drug effect, predictable, dose related
- ex: an ABX causing GI upset
what is a toxic reaction and give example
- an exaggeration of the clinical effect, predictable, dose related, happens when you take too much of. adrug
- EX: taking beta blocker twice -> drop in BP and dizzy
describe an allergic reaction
immune mediated responses, happen quickly and are very dangerous
what is the positive to dental drugs
- primarily single dose or short term tx
- large margin of safety
- extensive hx of use
what is pharmacokinetics
what the body does to the drug
what is pharmacodynamics
what the drug does to the body
how do we use kinetics
- important in drug development and clinical testing, needed to determine optimal dose
how are kinetics important in the clinical setting
- toxicology
- therapeutic monitoring
- drug interactions
- dose adjustments
- effect of illness, organ dysfunction